Carulli Michael
SEC CIK 2006668 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| PMVP | PMV Pharmaceuticals, Inc. | CFO | 60.1K | — | $34.3K | 3 | 2024-01-18 | 2025-07-01 |
Most active insiders at PMVP, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | OrbiMed Capital GP V LLC | 10% | — | $1.52M |
| 2 | Mack David Henry | Pres, CEO, Dir | — | — |
Carulli Michael made no open-market trades at PMVP in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-07-03 | 2025-07-01 | PMVP | PMV Pharmaceuticals, Inc. | Carulli Michael | CFO | S - Sale | $1.06 | -28.2K | 60.1K | -32% | -$29.9K | |
| 2024-09-12 | 2024-09-11 | PMVP | PMV Pharmaceuticals, Inc. | Carulli Michael | CFO | S - Sale | $1.50 | -2,891 | 88.4K | -3% | -$4,336 | |
| D | 2024-01-22 | 2024-01-18 | PMVP | PMV Pharmaceuticals, Inc. | Carulli Michael | CFO | A - Grant | $0.00 | +82.2K | 91.3K | +907% | $0 |
Purchase Sale Sale after option exercise All abbreviations